TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Sweetness liking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sweetness intensity perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Weekly Mean Pain NRS Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: sensory thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG change (1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: EEG change (2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of unplanned/unanticipated surgical breast procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Change in performance of the Hotel Task
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in the Canadian Occupational Performance Measure
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in Goal Attainment Scaling
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Practice performance evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reintroduction Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Neck range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of subjects with a Hoogland score of 5-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Positive and Negative Affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ASAS40 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Frequency of UTIs
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline Body Fat Percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline Waist Circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Functional Independence Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Spinal Cord Independence Measure (SCIM) III
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ASIA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Walking Index for Spinal Cord Injury II (WISCI II)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Visual learning test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual working memory test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: MoCA-K; Korean Version of the Montreal Cognitive Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Stability of Fixation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate to 11 vaccine serotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With Clinically Significant Trends in Vital Signs Over the Period of Study Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change From Baseline in Hemoglobin for Participants With Significant Hemoglobin Drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Level of heavy metal in blood and urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of high grade neurotoxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participant Phone Surveys Conducted
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Minimally Trained Personnel Who Achieve Assay Proficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of women with perceived occupational exposures at risk for their baby
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Depth and duration of HBsAg decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year survival without cerebral palsy
Endpoint domain: Mortality/survival
Primary endpoint: SUV-max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of Low-grade squamous intraepithelial lesion or worse (LSIL+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of Roux stasis syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Interleukin 6 and Interleukin 10 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in ovarian reserve function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Median atropine dose required in first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who required intubation or developed intermediate syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days ventilated and required ICU care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention rate under treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: duration of response until progression or death
Endpoint domain: Mortality/survival
Primary endpoint: Postoperatory EVA values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for rescue analgesia with IV morphine
Endpoint domain: Adverse events/effects
Primary endpoint: Change in sexual functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in communication about sex
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in perceived self efficacy in coping with sexual and intimate changes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: recurrence of atrial fibrillation (AF) and atrial flutter/tachycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with healthy transplanted teeth (clinical examination)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with healthy transplanted teeth (radiological examination)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: feNO level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cardiopulmonary Exercise Test Work Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of NIV failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in exercise pulmonary vascular resistance (PVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Engraftment Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Acute Graft-versus-host Disease
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Chronic Graft-versus-host Disease
Endpoint domain: Adverse events/effects
Primary endpoint: Change in PCL Measures Pre to Post-Intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PHQ Measures Pre to Post-Intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in PTCI Measures Pre to Post-Intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Scaffold thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: Steady-state Cmax and AUC (0-t) of atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Benchmark Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Injection Satisfaction Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Autism symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Developmental level
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Adaptive behavior
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC) for Caffeine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) for Caffeine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent Terminal Phase Half-life (t1/2) for Caffeine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of liver parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Curve (AUC) of Viral Shedding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: First episode of laboratory-confirmed A(H1N1)v infection
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse events after mCTLs infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Military to Civilian Questionnaire (Change)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-deployment Readjustment Inventory (Change)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: State-Trait Anger Expression Inventory (STAXI-2) (Change)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mass balance recovery of total radioactivity in all excreta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Presence of endotracheal tube in trachea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: slope of the torque curve force-ankle joint angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of patients having hard events (death, MI)
Endpoint domain: Mortality/survival
Primary endpoint: Endogenous CETP activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical performance Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety Profile Assessment
Endpoint domain: Adverse events/effects
Primary endpoint: Reducing carer burden
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Improving behaviour problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reducing the costs of illness
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Persistence of a stoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: percent of intrahepatic fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: block success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ease of nerve localization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of bleeding or entry site complications
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Pre-eclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Occurrence of SGA (Small for Gestational Age)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Menopausal complaints
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum IgG antibody concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Progression-Free Survival (PFS) Rate at 36 Weeks
Endpoint domain: Mortality/survival
Primary endpoint: Overall Objective Response Rate According to RECIST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment-related symptom burden
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Diagnostic Accuracy of CCTA Plus FFRCT and CCTA Alone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Striatal dopaminergic efflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Protein oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DNA modification by lipid adducts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Drug-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Contact heat evoked potentials (CHEPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Psychiatric diagnosis at 6-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opiorphin levels in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic and molecular indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Development of biomarkers for early detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence surveillance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery time to Modified Observer's Assessment of Alertness and Sedation Scale (MOAAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery time to ambulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative urinary complications
Endpoint domain: Adverse events/effects
Primary endpoint: Percent Change From Baseline in Fasting Triglycerides Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dyslipidemia measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants With Agonal Breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tear film volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular surface damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Filtration coefficient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Rankin Score (MRS) on day 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in NIHSS on day 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Response at Week 24 according to mBICLA Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Cancer Survivors Maintaining LVEF ≥50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pure tone Audiometry Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech Audiometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech Discrimination in Noise Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of occlusal surface change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of the opposing teeth hard tissue change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Subjective pain change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Mayo Elbow Performance Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Defense and Veterans Pain Rating Scale (DVPRS) from before surgery to after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Patient Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) from before surgery to after surgery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in the Patient Reported Outcomes Measurement Information System (PROMIS) Pain Interference (PI) from before surgery to after surgery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: change in processing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of atrial fibrillation after ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in cardiac structure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in pulmonary vascular structure and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy of NGAL to predict no response to albumin expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foetal macrosomia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DNA methylation level in macrosomia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in subjective hip value (SHV)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction of Grade II esophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Low Back Pain at Resting Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability for Low Back Pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Visual Analog Scale of Low Back Pain During Rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of appetite
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: flow mediated dilation of the brachial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic Performance of Anti-[18F]FACBC PET-CT Imaging in Detection of Recurrent Prostate Carcinoma in the Prostate Bed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac iron levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Posterior capsule evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of albuminuria screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total number of detected albuminuria cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Tissue levels of Klotho and FGF23
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of COPD exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pre-dose morning FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of hospital infections
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of staphylococcus aureus positive cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: concentration of sulbactam in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean VAS score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline ratio of the range of motion of the stabilized lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes from Baseline of the mean absolute deviation of lumbar angular displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of Patients Free From Breast Cancer
Endpoint domain: Mortality/survival
Primary endpoint: Volume of Pulmonary Contusion on CT scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of serum inflammatory mediator levels in BAL fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total oesophageal transit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time at which 10% radiolabel administered has arrived in the oesophagus from the mouth (T10%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time at which 50% radiolabel administered has arrived in the oesophagus from the mouth (T50%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Post-eruptive breakdown
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of Participants With HIV RNA Levels <50 Copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes